FDA 483 - Glaukos Corporation - April 22, 2025

An FDA inspection of Glaukos Corporation in San Clemente, CA, a manufacturer of combo drug/device intracameral implants, identified one observation. The firm failed to thoroughly review an unexplained discrepancy involving foreign material found during the filling of their iDose product. This indicates a lapse in quality system procedures for investigating product issues.